mAbxience Research SL is a Spanish corporation headquartered in Madrid that specializes in creating, producing, and selling biopharmaceutical medications. The business was established in 2015. mAbxience, a fully integrated global biopharmaceutical company that specializes in the creation, manufacturing, and commercialization of monoclonal antibodies, is a component of the pharmaceutical group Insud Pharma. mAbxience, which was established in 2010, runs three cutting-edge facilities in Spain and Argentina. The business is working on a number of biopharmaceutical goods for a variety of therapeutic areas.

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Neoplasms	1

Top 5 Drug Type	Count

Monoclonal antibody	2
Biosimilar	2

Top 5 Target	Count

VEGF-A(Vascular endothelial growth factor A)	1
RSV F protein(Respiratory syncytial virus F protein)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 03 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

Approved

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Bevacizumab biosimilar (mAbxience) ( VEGF-A )	Metastatic Non-Squamous Non-Small Cell Lung Carcinoma More	Approved
Palivizumab biosimilar(mAbxience Research) ( RSV F protein )	Respiratory Syncytial Virus Infections More	Phase 1

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis